AbbVie’s Humira missed Wall Street’s expectations in the third quarter but Skyrizi and Rinvoq’s continuing outperformance ...

Pre-Filled Syringes West Coast ... critical processes in design of combination products and implications in scaling up with David Post (AbbVie); Navigating injection technologies for reliable ...

Terence Flynn, an analyst from Morgan Stanley, reiterated the Buy rating on AbbVie (ABBV – Research Report). The associated price target ...

early on to identify unmet needs and opportunities Discussing the future of pre-filled syringe injection devices, with representatives from AbbVie, Pfizer, Genentech, Ferring Pharmaceuticals ...